Leveraging Computational Pathology to Expand Patient Stratification & Biomarker Development in Spatial Biology
Time: 3:45 pm
day: Day Two
Details:
- How AI-driven digital pathology is identifying non-binary biomarkers and expanding patient populations beyond conventional markers
- Practical strategies for integrating computational pathology into early-phase drug development and translational pipelines
- Lessons learned in standardizing digital pathology workflows to enable robust spatial biomarker discovery and clinical implementation
